Enacted in January 31, 2019 and most recently revised in June 15, 2026 and applied from Vol 8, No 2 (October 2026)
STUDY CONDUCT AND POLICIES
1. Research and publication ethics
In regard to the process of reviewing and assessing the manuscripts, including the ethical guidelines and plagiarism/ duplicate publication and study misconduct, it should conform to the ethical guidelines specified in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations/), which were established by the International Committee of Medical Journal Editors (ICMJE). For the policies on the research and publication ethics not stated in this instruction, Good Publication Practice Guidelines for Medical Journals 3rd (Korean Association of Medical Journal Editors, KAMJE; http://kamje.or.kr/intro.php?body=publishing_eth-ics) or Guidelines on Good Publication (Committee on Publication Ethics, COPE; http://publicationethics.org/resources/guidelines) can be applied.
2. Disclosure of conflicts of interest
Financial sponsorship should be stated in the conflicts of interest. Any other financial support associated with the study, including stocks or consultation arrangements with pharmaceutical companies should be stated at the end of the text, under a subheading “Conflicts of interest.”
3. Statement of informed consent
Human study must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedures must appear at the beginning of the “Methods” section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editor-in-Chief may request a copy of the approved IRB application from the author.
4. Statement of human and animal right
Clinical research studies must state that the work was done in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Declaration of Helsinki in 1975 (revised in 2013; http:// www.wma.net/en/30publications/10policies/b3/index. html). Clinical studies that do not meet the Declaration of Helsinki will not be considered for publication. Human subjects must not be identifiable. Patients’ name, initial, hospital number, date of birth, or other protected health- care information must not be disclosed.
Animal research studies must state that the work was performed according to National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals must be observed. For experimental studies involving client-owned animals, authors must also include a statement on informed consent from the client or owner.
5. Authorship
The JIG follows the recommendations for authorship by the ICMJE, 2019 (http://www.icmje.org/icmje-recommendations.pdf) and Good Publication Practice Guidelines for Medical Journals 3rd Edition (KAMJE, 2019, https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=). Authorship credit must be based on 1) substantial contributions to the concept and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors must meet the above four conditions.
A corresponding author should be designated when there are two or more authors. The corresponding author is primarily responsible for all issues to the editor and audience. Any comment of the corresponding author is regarded as opinion of all coauthors.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
6. Originality and duplicate publication
All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. No part of the accepted paper should be duplicated in another scientific journal without permission by Editorial Board. If duplicate publications related to the papers of this journal are detected, sanctions against authors range from requesting their institutions to assess the facts, requesting a Letter to the Editor-in-Chief acknowledging the error and voluntarily withdrawing a paper, to a ban on publication in JIG up to 3 years.
7. Sex and gender equity in research
We encourage the use of the Sex and Gender Equity in Research (SAGER) guidelines (http://doi.org/10.1186/s41073016-0007-6) for reporting of sex (biological factor) and gender (identify, psychosocial or cultural factors) information in study design, data analysis, and manuscripts writing.
Artificial Intelligence (AI) Use
Policy
The JIG
recognizes the potential benefits of AI technologies in scientific writing and
research. To ensure transparency, accountability, and research integrity, JIG
adopts the following policy regarding the use of AI.
1) AI
technologies, including large language models, machine learning tools, and
similar technologies, does not qualify for authorship and may not be listed as
an author or co-author.
2) Authors
are fully responsible for all submitted content, including any material
generated or assisted by AI.
3) Authors
who use AI in manuscript preparation must disclose its use in both the cover
letter and the manuscript, including the tool name, version, and purpose of
use.
4) Any
AI-generated or AI-assisted images, figures, graphical abstracts, or
illustrations must be explicitly disclosed.
5) Authors must
verify the accuracy, validity, and appropriateness of all AI-generated content,
including references and citations.
6) Authors must not upload
identifiable patient information, genomic data, or confidential research data
to publicly accessible AI platforms without appropriate authorization and data
protection measures.
7) The
use of AI solely for language editing, grammar correction, or readability
improvement does not require disclosure.
8) Reviewers
and editors must not upload submitted manuscripts or confidential editorial
materials to external AI platforms.
9) The
Editorial Board reserves the right to request disclosure of AI use and to
verify compliance with this policy.
--------------------------------------------------------------------------------------------
[example] Submit materials to Journal of
Interdisciplinary Genomics:
Research
Ethics Compliance Statement
I will not engage in any misconduct, such as
ghostwriting or plagiarism, regarding the title, table of contents, or contents
of the paper, and I pledge to strictly comply with the research ethics
guidelines and submit a research ethics compliance form. I declare that I will
not object to any sanctions in case of violation of the above.